Related Experiment Videos
Medical treatment of Parkinson's disease
1Department of Neurology, Columbia University College of Physicians & Surgeons, Neurological Institute, New York, NY 10032, USA. fahn@movdis.cis.columbia.edu
Journal of Neurology
|November 10, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Alpha galactosidase A activity in Parkinson's disease.
Neurobiology of disease·2018
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
Movement disorders : official journal of the Movement Disorder Society·2017
Inpatient treatment for functional neurologic disorders.
Handbook of clinical neurology·2016
Increased Rate of Sporadic and Recurrent Rare Genic Copy Number Variants in Parkinson's Disease Among Ashkenazi Jews.
Molecular genetics & genomic medicine·2013
Distinct small-fiber dysfunction profiles in CMT1A and RFC1 disease: a multimodal study.
Journal of neurology·2026
Oral PCSK9 inhibitors: closing the gap between potency and practicality.
Current opinion in lipidology·2026
SGLT2 Inhibitors: Dual Effects on Erythropoiesis and Bone Metabolism.
Journal of bone metabolism·2026
Public funding for paediatric medications in Canada.
Paediatrics & child health·2026
Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.
The Journal of membrane biology·2026
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026